Concepedia

Shiri Davidi

SD

Statistics

Publications

6

Citations

324

H-Index

6

Active since

2014

Affiliations

Novocure (United States)(Current)

Shiri Davidi is an author at Novocure (United States) specializing in medicine, oncology, and tumor microenvironment modulation.

Publications per year

2014–2022

6

Publications

6

Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy

Tali Voloshin, Noa Kaynan, Shiri Davidi et al. · Cancer Immunology Immunotherapy · 2020 · 168 citations · Full text

Medicine, Immunology, Oncology +17

Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models

Yelena Mumblat, Antonia Martinez-Conde, Ori Braten et al. · Lung Cancer · 2021 · 50 citations

Medicine, Oncology, Pharmacology +14

Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo

Shiri Davidi, Sara Jacobovitch, Anna Shteingauz et al. · Cancers · 2022 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +15

In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso

Roni Blatt, Shiri Davidi, Mijal Munster et al. · Frontiers in Oncology · 2021 · 30 citations · Full text

Medicine, Oncology, Radiation Oncology +15

The antiangiogenic role of the pro-inflammatory cytokine interleukin-31

Shiri Davidi, Ella Fremder, Tal Kan et al. · Oncotarget · 2017 · 27 citations · Full text

Medicine, Cancer Biology, Oncology +14

1–5 of 6